“This approach harnesses the transformative potential of transcription factor biology to guide iPSC cell fate into any ...

A study uncovers how histone modifications, specifically in the H3.3 protein, regulate gene expression in mouse stem cells.

Astrocytes in the brain exhibit significant regional diversity, but the mechanisms controlling their heterogeneity remain ...

"Unexpectedly, we ended up discovering that cell membrane damage, in a sense, switches cell fate." The key to determining cell fate is the extent of damage and subsequent calcium ion influx. The thin ...

“This approach harnesses the transformative potential of transcription factor biology to guide iPSC cell fate into any differentiated cell type in a single, seamless step. By transcending the ...

Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

I’ve been here for nearly 32 years. Whether I like it or not, the holes in the bricks, the smells of the pipes, the stains in ...

A New Ventilator-on-a-Chip Model to Study Lung Damage Sep. 19, 2024 — Scientists are now able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular ...

Fate is focused on the development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. Its immuno-oncology ...